Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.

Cited by (581)

Items 101–200 of 581

1. Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of Steroidogenic Factor-1 and Chicken Ovalbumin Upstream Promoter Transcription Factor to the Same cis-Acting Element
   Zeitoun, Khaled, Takayama, Kazuto, Michael, M. Dod, Bulun, Serdar E. · 1999 · Molecular Endocrinology
2. The SMRT Corepressor Is Regulated by a MEK-1 Kinase Pathway: Inhibition of Corepressor Function Is Associated with SMRT Phosphorylation and Nuclear Export
   Suk-hyun Hong, M. Privalsky · 2000 · Molecular and Cellular Biology
3. Modulation of Estrogen Receptor-α Transcriptional Activity by the Coactivator PGC-1
   Irina Y. Tcherepanova, Pere Puigserver, John D. Norris, Bruce M. Spiegelman, Donald Patrick McDonnell · 2000 · Journal of Biological Chemistry
4. Cell Signaling Switches HOX-PBX Complexes from Repressors to Activators of Transcription Mediated by Histone Deacetylases and Histone Acetyltransferases
   Maya Saleh, Isabel Rambaldi, Xiang‐Jiao Yang, Mark Featherstone · 2000 · Molecular and Cellular Biology
5. Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
   Wenlin Shao, Myles A Brown · 2003 · Breast Cancer Research
6. Transcription in four dimensions: nuclear receptor‐directed initiation of gene expression
   R. Métivier, G. Reid, F. Gannon · 2006 · EMBO Reports
7. Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT*
   Guoqing Liao, Liuh-Yow Chen, A. Zhang, Aparna Godavarthy, Fang Xia, J. C. Ghosh, Hui Li, J. Chen · 2003 · Journal of Biological Chemistry
8. Tamoxifen Resistance in Breast Cancer
   Min-Sun Chang · 2012 · Biomolecules & Therapeutics
9. DAX-1 Functions as an LXXLL-containing Corepressor for Activated Estrogen Receptors
   Hui Zhang, Jane S. Thomsen, Lotta Johansson, Jan-Ακε Gustafsson, Eckardt Treuter · 2000 · Journal of Biological Chemistry
10. Statistical analysis of array expression data as applied to the problem of tamoxifen resistance.
    S. Hilsenbeck, W. Friedrichs, R. Schiff, P. O’Connell, R. Hansen, C. Osborne, S. Fuqua · 1999 · Journal of the National Cancer Institute
11. Activation of nuclear receptors: a perspective from structural genomics.
    Yong Li, M. Lambert, H.-E. Xu · 2003 · Structure
12. Selective estrogen receptor modulators: tissue specificity and clinical utility
    John A. Arnott, Stephen C. Martinkovich, Sonia Lobo Planey, Darshan Shah · 2014 · Clinical Interventions in Aging
13. A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-activated Receptor γ-activating Properties
    Mauricio J. Reginato, Shannon Terrell Bailey, Samuel L. Krakow, Chieko Minami, Shin‐ichi Ishii, Hideho Tanaka, Mitchell A. Lazar · 1998 · Journal of Biological Chemistry
14. Regulation of the Transcriptional Activity of the Peroxisome Proliferator-activated Receptor α by Phosphorylation of a Ligand-independent trans-Activating Domain
    Cristiana E. Juge-Aubry, Eva B. Hammar, Catherine A. Siegrist-Kaiser, Agnès Pernin, Akira Takeshita, William W. Chin, Albert Burger, Christoph Andreas Meier · 1999 · Journal of Biological Chemistry
15. Peroxisome Proliferator-activated Receptor δ (PPARδ)-mediated Regulation of Preadipocyte Proliferation and Gene Expression Is Dependent on cAMP Signaling*
    J. Hansen, H. Zhang, T. H. Rasmussen, R. Petersen, E. Flindt, K. Kristiansen · 2001 · Journal of Biological Chemistry
16. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors α and β by coactivators and corepressors
    C. Klinge, S. C. Jernigan, K. Mattingly, K. E. Risinger, J. Zhang · 2004 · Journal of Molecular Endocrinology
17. Unique forms of human and mouse nuclear receptor corepressor SMRT.
    P. Ordentlich, M. Downes, W. Xie, A. Genin, N. Spinner, R. Evans · 1999 · Proceedings of the National Academy of Sciences of the United States of America
18. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle
    Gilde, A. J., Van Bilsen, M. · 2003 · Acta Physiologica Scandinavica
19. Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review)
    Rubí Viedma‐Rodríguez, Luís Arturo Baiza-Gutman, Fabio Salamanca-Gómez, Mariana Díaz-Zaragoza, Guadalupe Martínez‐Hernández, Ruth Ruiz-Esparza Garrido, Miguel Ángel Velázquez-Flores, Diego Julio Arenas-Aranda · 2014 · Oncology Reports
20. Transcriptional Regulation by Steroid Receptor Coactivator Phosphorylation
    Ray‐Chang Wu, Carolyn L. Smith, Bert W. O’Malley · 2005 · Endocrine Reviews
21. Bidirectional cross talk between ERα and EGFR signalling pathways regulates tamoxifen-resistant growth
    David Britton, I. Hutcheson, J. Knowlden, D. Barrow, M. Giles, R. Mcclelland, J. Gee, R. I. Nicholson · 2006 · Breast Cancer Research and Treatment
22. Steroid receptor coactivators 1, 2, and 3: Critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy
    Amber Buescher Johnson, Bert W. O’Malley · 2011 · Molecular and Cellular Endocrinology
23. Forkhead Homologue in Rhabdomyosarcoma Functions as a Bifunctional Nuclear Receptor-interacting Protein with Both Coactivator and Corepressor Functions
    Holly Hong Zhao, Rafael E. Herrera, Ester B. Coronado, Michael Yang, John H. Ludes-Meyers, Karen J. Seybold-Tilson, Zafar Nawaz, Douglas Yee, Frederic G. Barr, Sami Diab et al. · 2001 · Journal of Biological Chemistry
24. The Role of Coactivators and Corepressors in the Biology and Mechanism of Action of Steroid Hormone Receptors
    Dean P. Edwards · 2000 · Journal of Mammary Gland Biology and Neoplasia
25. Ligand-Independent Interactions of p160/Steroid Receptor Coactivators and CREB-Binding Protein (CBP) with Estrogen Receptor-α: Regulation by Phosphorylation Sites in the A/B Region Depends on Other Receptor Domains
    Martin Dutertre, Carolyn L. Smith · 2003 · Molecular Endocrinology
26. DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation.
    Hollie I. Swanson · 2002 · Chemico-Biological Interactions
27. Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev
    T. R. Reddy, Wei-Dong Xu, J. K. L. Mau, C. D. Goodwin, M. Suhasini, Heng-Li Tang, K. Frimpong, D. Rose, F. Wong-Staal · 1999 · Nature Medicine
28. Comparative analyses of mechanistic differences among antiestrogens.
    A. Wijayaratne, S. Nagel, L. A. Paige, D. Christensen, J. Norris, D. Fowlkes, D. McDonnell · 1999 · Endocrinology
29. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions
    David Michael Lonard, C S Smith · 2002 · Steroids
30. RU486-induced Glucocorticoid Receptor Agonism Is Controlled by the Receptor N Terminus and by Corepressor Binding*
    M. Schulz, M. Eggert, A. Baniahmad, A. Dostert, T. Heinzel, R. Renkawitz · 2002 · Journal of Biological Chemistry
31. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators
    R. Schiff, S. Massarweh, Jiang Shou, L. Bharwani, G. Arpino, M. Rimawi, C. Osborne · 2005 · Cancer Chemotherapy and Pharmacology
32. Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer.
    C. Osborne, R. Schiff · 2003 · Breast
33. A role for RNA helicase A in post-transcriptional regulation of HIV type 1.
    Jun-Zhou Li, Heng-Li Tang, T. Mullen, Christopher Westberg, T. R. Reddy, D. Rose, F. Wong-staal · 1999 · Proceedings of the National Academy of Sciences of the United States of America
34. Recruitment of Distinct Chromatin-modifying Complexes by Tamoxifen-complexed Estrogen Receptor at Natural Target Gene Promoters in Vivo*
    Xue-Feng Liu, M. Bagchi · 2004 · Journal of Biological Chemistry
35. Identification of Nuclear Receptor Corepressor as a Peroxisome Proliferator-activated Receptor α Interacting Protein
    Paul Dowell, Jane E. Ishmael, Dorina Avram, Valerie J. Peterson, Daniel J. Nevrivy, Mark E. Leid · 1999 · Journal of Biological Chemistry
36. Minireview: Nuclear Receptors and Breast Cancer
    Suzanne Daniela Conzen · 2008 · Molecular Endocrinology
37. Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors
    J. W. Lee*, Y. C. Lee, S.-Y. Na, Dong-Ju Jung, S.-K. Lee · 2001 · Cellular and Molecular Life Sciences
38. Tissue-specific estrogenic response and molecular mechanisms.
    P. Diel · 2002 · Toxicology Letters
39. Apoptotic Action of 17β-Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo
    Hong Liu, Eun Sook Lee, C. Gajdos, S. Pearce, Bin Chen, C. Osipo, Jessica A. Loweth, K. Mckian, A. De Los Reyes, Laura K. Wing et al. · 2003 · JNCI Journal of the National Cancer Institute
40. Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance
    P. Schoenlein, Sudharsan Periyasamy‐Thandavan, Julia S. Samaddar, W. Jackson, J. Barrett · 2009 · Autophagy
41. Estrogen receptor corepressors -- a role in human breast cancer?
    Klaudia M. Dobrzycka, Steven Matthew Townson, Shiming Jiang, Steffi Oesterreich · 2003 · Endocrine Related Cancer
42. Nuclear receptors: recent drug discovery for cancer therapies
    Linjie Zhao, Shengtao Zhou, Jan-Ακε Gustafsson · 2019 · Endocrine Reviews
43. Pathways to Endocrine Therapy Resistance in Breast Cancer
    Md. Moquitul Haque, Kartiki Vasant Desai · 2019 · Frontiers in Endocrinology
44. Ligand-independent Activation of Steroid Receptors: New Roles for Old Players.
    B. Cenni, D. Picard · 1999 · Trends in endocrinology and metabolism
45. Estrogen Receptor and Breast Cancer
    Stephanie Sommer, S. Fuqua · 2001 · Cancer Drug Discovery and Development
46. Differential SERM Effects on Corepressor Binding Dictate ERα Activity in Vivo *
    P. Webb, P. Nguyen, P. Kushner · 2003 · Journal of Biological Chemistry
47. A Dynamic Structural Model for Estrogen Receptor-α Activation by Ligands, Emphasizing the Role of Interactions between Distant A and E Domains
    Raphaël Métivier, Alexander Stark, Gilles Flouriot, Michael R. Hübner, Heike Brand, Graziella Penot, Dominique Manu, Stefanie Denger, George Reid, Martin Koš et al. · 2002 · Molecular Cell
48. Lessons learnt from structural studies of the oestrogen receptor.
    A. Pike · 2006 · Best practice & research. Clinical endocrinology & metabolism
49. Comparative Analyses of Mechanistic Differences Among Antiestrogens1.
    A. Wijayaratne, S. Nagel, L. A. Paige, D. Christensen, J. Norris, D. Fowlkes, D. McDonnell · 1999 · Endocrinology
50. Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple
    Bramanandam Manavathi, Oindrilla Dey, Vijaya Narasihma Reddy Gajulapalli, Raghavendra Singh Bhatia, Suresh Bugide, Rakesh Kumar · 2012 · Endocrine Reviews
51. Molecular and pharmacological aspects of antiestrogen resistance.
    R. Clarke, T. Skaar, K. Bouker, Natalie Davis, YRJ. Lee, J. N. Welch, F. Leonessa · 2001 · Journal of Steroid Biochemistry and Molecular Biology
52. Coactivators and corepressors as mediators of nuclear receptor function: An update
    Guido W Jenster · 1998 · Molecular and Cellular Endocrinology
53. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon, Ho-Geun, Wong, Jiemin · 2006 · Molecular Endocrinology
54. T:G Mismatch-specific Thymine-DNA Glycosylase Potentiates Transcription of Estrogen-regulated Genes through Direct Interaction with Estrogen Receptor α
    Dongsheng Chen, Marie J. Lucey, Fladia A. Phoenix, Jorge Lopez-Garcia, SM Hart, Régine Losson, Laki Buluwela, R. Charles Coombes, Pierre Chambon, Primo Schär et al. · 2003 · Journal of Biological Chemistry
55. Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer
    Lu, Yunlong, Liu, Wukun · 2020 · Journal of Medicinal Chemistry
56. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
    D. Szapary, Ying Huang, S. Simons · 1999 · Molecular Endocrinology
57. Transcriptional Activities of Retinoic Acid Receptors
    Philippe Lefèbvre, P. J. Martin, Sébastien Flajollet, Stéphane Dedieu, Xavier Billaut, Bruno Lefebvre · 2005 · Vitamins and hormones
58. The changing role of ER in endocrine resistance
    Agostina Nardone, Carmine De Angelis, Meghana V. Trivedi, Charles Kent Osborne, Rachel Schiff · 2015 · The Breast
59. Retinoids in biological control and cancer
    Anthonise Louis Fields, D. Soprano, K. Soprano · 2007 · Journal of Cellular Biochemistry
60. Molecular Cloning and Characterization of CAPER, a Novel Coactivator of Activating Protein-1 and Estrogen Receptors
    Dong-Ju Jung, Soon‐Young Na, Doe Sun Na, Jae Woon Lee · 2002 · Journal of Biological Chemistry
61. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    E. Keeton, Myles A. Brown · 2005 · Molecular Endocrinology
62. A Novel Role for Helix 12 of Retinoid X Receptor in Regulating Repression
    Jin-Song Zhang, Xiao Hu, M. Lazar · 1999 · Molecular and Cellular Biology
63. Molecular Mechanisms, Physiological Consequences and Pharmacological Implications of Estrogen Receptor Action
    Tomas Barkhem, Stefan V. Nilsson, Jan- ke Gustafsson · 2004 · American Journal of PharmacoGenomics
64. Estrogen signaling: An emanating therapeutic target for breast cancer treatment
    Tanmay Saha, Subhajit Makar, Rayala Swetha, Gopichand Gutti, Sushil Kumar Singh · 2019 · European Journal of Medicinal Chemistry
65. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
    Huey-Jing Huang, J. Norris, D. McDonnell · 2002 · Molecular Endocrinology
66. A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity
    Isabelle Dussault, Min Lin, Kevin Hollister, Ming Qi Fan, John S. Termini, Mark A. Sherman, BARRY MARC FORMAN · 2002 · Molecular and Cellular Biology
67. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor δ-mediated transactivation
    Anne Krogsdam, Curt A. F. Nielsen, Søren Neve, Dorte Holst, Torben Helledie, Bo Thomsen, Christian Bendixen, Susanne Mandrup, Karsten Kristiansen · 2002 · Biochemical Journal
68. Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2–ERα–GREB1 Transcriptional Axis
    Yanming Wu, Zhao Zhang, Mauro E. Cenciarini, Cecilia Jazmín Proietti, Matías Amasino, Tao Hong, Mei Yang, Yiji Liao, Huai-Chin Chiang, Virginia Kaklamani et al. · 2017 · Cancer Research
69. Biological mechanisms and clinical implications of endocrine resistance in breast cancer.
    M. Giuliano, R. Schiff, C. Osborne, Meghana V. Trivedi · 2011 · Breast
70. Selective estrogen-receptor modulators for primary prevention of breast cancer.
    C. Fabian, B. Kimler · 2005 · Journal of Clinical Oncology
71. Multiple Regions of ETO Cooperate in Transcriptional Repression*
    Daniel Hildebrand, Jens Tiefenbach, T. Heinzel, M. Grez, A. Maurer · 2001 · Journal of Biological Chemistry
72. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
    S. Oesterreich, Qing-Ping Zhang, Torsten A. Hopp, Suzanne A. W. Fuqua, M. Michaelis, Holly Hong Zhao, J. Davie, C. Osborne, A. V. Lee · 2000 · Molecular Endocrinology
73. A role for cadherins in cellular signaling and differentiation
    Karen A. Knudsen, Christy Frankowski, Keith R. Johnson, Margaret J. Wheelock · 1998 · Journal of Cellular Biochemistry
74. Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer
    R. Nicholson, J. Gee · 2000 · British Journal of Cancer
75. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Qi Wang, J. Blackford, Liang-Nian Song, Ying Huang, Sehyung Cho, S. Simons · 2004 · Molecular Endocrinology
76. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
    Y. Shah, B. Rowan · 2005 · Molecular Endocrinology
77. Identification of a Phosphorylation Site in the Hinge Region of the Human Progesterone Receptor and Additional Amino-terminal Phosphorylation Sites*
    Trina A. Knotts, R. Orkiszewski, R. Cook, D. Edwards, N. Weigel · 2001 · Journal of Biological Chemistry
78. Interdomain Signaling in a Two-domain Fragment of the Human Glucocorticoid Receptor*
    Raj Kumar, I. Baskakov, G. Srinivasan, D. Bolen, Ching J. Lee, E. Thompson · 1999 · Journal of Biological Chemistry
79. Estrogenic Regulation of the GnRH Neuron
    Radovick, Sally, Levine, Jon E., Wolfe, Andrew · 2012 · Frontiers in Endocrinology
80. Expression of Sex Steroid Receptors and their Co-Factors in Normal and Malignant Breast Tissue: AIB1 is a Carcinoma-Specific Co-Activator
    G. Hudelist, K. Czerwenka, E. Kubista, Erika Marton, K. Pischinger, C. Singer · 2003 · Breast Cancer Research and Treatment
81. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    F. Fleming, A. Hill, E. Mcdermott, N. O'Higgins, L. Young · 2004 · Journal of Clinical Endocrinology and Metabolism
82. SMRT and N-CoR Corepressors Are Regulated by Distinct Kinase Signaling Pathways*
    B. Jonas, M. Privalsky · 2004 · Journal of Biological Chemistry
83. Estrogen receptor cofactors expression in breast and endometrial human cancer cells.
    S. Thénot, M. Charpin, S. Bonnet, V. Cavaillès · 1999 · Molecular and Cellular Endocrinology
84. Expression of Nuclear Receptors and Cofacotrs in Human Endometrium and Myometrium
    A. Vienonen, S. Miettinen, M. Bläuer, P. Martikainen, E. Tomás, P. Heinonen, T. Ylikomi · 2004 · Journal of the Society for Gynecologic Investigation
85. Histone deacetylase inhibition and estrogen signalling in human breast cancer cells.
    R. Margueron, V. Duong, A. Castet, V. Cavaillès · 2004 · Biochemical Pharmacology
86. Novel Mechanism of Nuclear Receptor Corepressor Interaction Dictated by Activation Function 2 Helix Determinants
    Anna N. Moraitis, Vincent Giguère, Catherine C. Thompson · 2002 · Molecular and Cellular Biology
87. Visualization of Estrogen Receptor Transcriptional Activation in Zebrafish
    Daniel A. Gorelick, Marnie E. Halpern · 2011 · Endocrinology
88. TR surfaces and conformations required to bind nuclear receptor corepressor.
    A. Marimuthu, Weijun Feng, T. Tagami, Hoa T. Nguyen, J. Jameson, R. J. Fletterick, J. D. Baxter, B. West · 2002 · Molecular Endocrinology
89. Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1).
    Hiroaki Fuse, H. Kitagawa, Shigeaki Kato · 2000 · Molecular Endocrinology
90. Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor α and β
    M. Pavao, A. Traish · 2001 · Steroids
91. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity
    Simon C. Gamble, D. Chotai, M. Odontiadis, D. A. Dart, G. Brooke, S. Powell, V. Reebye, A. Varela‐Carver, Y. Kawano, J. Waxman et al. · 2007 · Oncogene
92. The Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Corepressor Is Required for Full Estrogen Receptor α Transcriptional Activity
    Theresa J Peterson, S. Karmakar, Margaret C. Pace, Tong Gao, Carolyn L. Smith · 2007 · Molecular and Cellular Biology
93. Full Activation of Estrogen Receptor α Activation Function-1 Induces Proliferation of Breast Cancer Cells
    Tetsuo Fujita, Yôko Kobayashi, Osamu Wada, Yukiyo Tateishi, Lina Kitada, Yasuji Yamamoto, Hisashige Takashima, Akiko Murayama, Tetsu Yano, Tadashi Baba et al. · 2003 · Journal of Biological Chemistry
94. Orphan Nuclear Receptors: From Gene to Function
    Vincent Giguère · 1999 · Endocrine Reviews
95. Antiestrogens and their therapeutic applications in breast cancer and other diseases.
    Simak Ali, L. Buluwela, R. Coombes · 2011 · Annual Review of Medicine
96. ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective
    Ruchi Saxena, Anila Dwivedi · 2010 · Medicinal Research Reviews
97. Ligand- and Coactivator-mediated Transactivation Function (AF2) of the Androgen Receptor Ligand-binding Domain Is Inhibited by the Cognate Hinge Region*
    Qi Wang, Jin-Hua Lu, E. Yong · 2001 · Journal of Biological Chemistry
98. Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
    Esmael Besufikad Belachew, Dareskedar Tsehay Sewasew · 2021 · Frontiers in Endocrinology
99. Structural Insights into Corepressor Recognition by Antagonist-bound Estrogen Receptors*
    N. Heldring, T. Pawson, D. McDonnell, E. Treuter, J. Gustafsson, A. Pike · 2007 · Journal of Biological Chemistry
100. Steroid Receptors and Their Role in the Biology and Control of Breast Cancer Growth
     Fernando Cordera, Virgil Craig Jordan · 2006 · Seminars in Oncology